|
Medley΄s portfolio includes prescription products marketed under Medley brands. We divide our business in 2 strategic units:
In-licensed products from R&D companies such as Bayer, Abbott, Isdin, Novo Nordisk, Recordati and Sanofi Aventis.
Plain Generics developed in-house as well as in-licensed - where Medley is the Brazilian market leader, with some 30% market share.
We focus our present in-licensing activities on the following therapeutic areas:
Cardiology
Dermatology
Gastroenterology
Gynaecology
Endocrinology
Urology
Paediatrics
| 
